financetom
Business
financetom
/
Business
/
Update: Snowflake's Shares Fall as Fiscal Q2 Non-GAAP Earnings Drop
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Snowflake's Shares Fall as Fiscal Q2 Non-GAAP Earnings Drop
Aug 23, 2024 10:51 PM

11:06 AM EDT, 08/22/2024 (MT Newswires) -- (Updates with stock move in the headline and first paragraph.)

Snowflake's (SNOW) shares fell nearly 13% in recent Thursday trading after the company reported non-GAAP fiscal Q2 net income of $0.18 per diluted share, down from $0.22 a year earlier.

Analysts polled by Capital IQ expected $0.16.

Revenue for the quarter ended July 31 was $868.8 million, compared with $674 million a year earlier.

Analysts expected $850.7 million.

The company's board approved its stock buyback program by another $2.5 billion, in addition to the $491.9 million remaining under the existing program. The board also extended the expiration date for the program by an extra two years to March 2027.

Price: 117.70, Change: -17.36, Percent Change: -12.85

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cloudflare Insider Sold Shares Worth $892,960, According to a Recent SEC Filing
Cloudflare Insider Sold Shares Worth $892,960, According to a Recent SEC Filing
Apr 25, 2024
04:52 PM EDT, 04/25/2024 (MT Newswires) -- Carl Ledbetter, Director, on April 24, 2024, sold 10,015 shares in Cloudflare ( NET ) for $892,960. Following the Form 4 filing with the SEC, Ledbetter has control over a total of 1,220,203 shares of the company, with 15,388 shares held directly and 1,204,815 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1477333/000141588924011520/xslF345X03/form4-04252024_080405.xml Price: 88.75, Change: +1.99,...
Gilead Sciences Q1 Tops Estimates, Updates Outlook
Gilead Sciences Q1 Tops Estimates, Updates Outlook
Apr 25, 2024
04:50 PM EDT, 04/25/2024 (MT Newswires) -- Gilead Sciences ( GILD ) late Thursday reported Q1 non-GAAP net loss of $1.32 per diluted share, compared with earnings of $1.37 last year. Analysts surveyed by Capital IQ expected a loss of $1.52 a share. Revenue for the quarter ended March 31 was $6.69 billion, up from $6.35 billion last year. Analysts...
Hartford Financial Q1 Core Earnings, Revenue Rise -- Shares Down After Hours
Hartford Financial Q1 Core Earnings, Revenue Rise -- Shares Down After Hours
Apr 25, 2024
04:54 PM EDT, 04/25/2024 (MT Newswires) -- Hartford Financial Services ( HIG ) Thursday reported Q1 core earnings of $2.34 per diluted share, up from $1.68 a year earlier. Analysts polled by Capital IQ expected $2.44, normalized. Revenue for the quarter ended March 31 was $6.42 billion, up from $5.91 billion a year earlier. Analysts expected $6.49 billion. Hartford shares...
Vaxcyte Insider Sold Shares Worth $928,845, According to a Recent SEC Filing
Vaxcyte Insider Sold Shares Worth $928,845, According to a Recent SEC Filing
Apr 25, 2024
04:56 PM EDT, 04/25/2024 (MT Newswires) -- Grant Pickering, Director, CEO, on April 23, 2024, sold 15,000 shares in Vaxcyte ( PCVX ) for $928,845. Following the Form 4 filing with the SEC, Pickering has control over a total of 772,571 shares of the company, with 477,847 shares held directly and 294,724 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1649094/000141588924011522/xslF345X03/form4-04252024_080442.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved